Cart
sales@molnova.com
Bestatin hydrochloride
CAS No. 65391-42-6
Bestatin hydrochloride( —— )
Catalog No. M15486 CAS No. 65391-42-6
Bestatin (Ubenimex) hydrochlorideis an inhibitor of aminopeptidase N (APN)/CD13 and aminopeptidase B.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 49 | In Stock |
|
| 5MG | 45 | In Stock |
|
| 10MG | 65 | In Stock |
|
| 25MG | 103 | In Stock |
|
| 50MG | 165 | In Stock |
|
| 100MG | 272 | In Stock |
|
| 200MG | 418 | In Stock |
|
| 500MG | 677 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBestatin hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionBestatin (Ubenimex) hydrochlorideis an inhibitor of aminopeptidase N (APN)/CD13 and aminopeptidase B.
-
DescriptionBestatin (Ubenimex) hydrochlorideis an inhibitor of aminopeptidase N (APN)/CD13 and aminopeptidase B.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetAminopeptidase
-
RecptorAminopeptidase| CD13
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number65391-42-6
-
Formula Weight344.84
-
Molecular FormulaC16H25ClN2O4
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCC(C)C[C@@H](C(=O)O)NC(=O)[C@H]([C@@H](CC1=CC=CC=C1)N)O.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Huo X. , et al. Enhancement effect of P-gp inhibitors on the intestinal absorption and antiproliferative activity of bestatin. Eur J Pharm Sci. 2013 Nov 20;50(3-4):420-8.
molnova catalog
related products
-
DG051
A potent, selective LTA4H (Leukotriene A4 hydrolase) inhibitor (IC50/Kd=47/25 nM) of leukotriene B4 biosynthesis.
-
Firibastat
QGC-001 is a glutamyl aminopeptidase antagonist and an orally active brain penetrating prodrug of EC33. It is a first-in-class brain aminopeptidase A (APA) inhibitor with a Ki of 200 nM.
-
ZGN-1061
ZGN-1061 (Aclimostat) is a novel potent, selective Methionine aminopeptidase 2 (MetAP2) inhibitor being investigated for treatment of diabetes and obesity.
